arrow
J

Jake R. Conway

Harvard University
H指数:16
被引数:6,635

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integration of deep learning-based histopathology and transcriptomics reveals key genes associated with fibrogenesis in patients with advanced NASH

基于深度学习的组织病理学和转录组学的整合揭示了与晚期NASH患者纤维化相关的关键基因

2023-04-019
OAAI
IDENTIFICATION OF CLINICALLY RELEVANT SPATIAL TISSUE PHENOTYPES IN LARGE-SCALE MULTIPLEX IMMUNOFLUORESCENCE DATA VIA UNSUPERVISED GRAPH LEARNING IN NON-SMALL CELL LUNG CANCER
2022-11-070
OA
Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncology

通过分子肿瘤学年鉴将分子概况整合到临床框架中,以前瞻性地指导精确肿瘤学

2021-09-3019
OA
Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer
2021-09-2128
OAAI
Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancer
2021-09-0129
OAAI
Gene Fusions Create Partner and Collateral Dependencies Essential to Cancer Cell Survival
2021-06-0714
OAAI
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade

治疗性增加mhc-i表达增强免疫检查点阻断

2021-02-15132
OA
Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and Melanoma

在前列腺癌和黑色素瘤患者中,使用深度学习与标准方法的种系基因检测检测致病性变异

2020-11-1724
OAAI
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma (vol 25, pg 1915, 2019)
2020-06-196
OAAI
A phase II study of cisplatin and the Wee1 inhibitor adavosertib in metastatic triple-negative breast cancer (mTNBC)
2020-02-150
PRE
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

转移性黑色素瘤患者PD1阻断的临床结果的整合分子和临床模型

2019-12-02606
OAAI